These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5295158)

  • 21. Long-term clearance of [57Co]cyanocobalamin in vegans and pernicious anaemia.
    Amin S; Spinks T; Ranicar A; Short MD; Hoffbrand AV
    Clin Sci (Lond); 1980 Jan; 58(1):101-3. PubMed ID: 6766367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radio-vitamin B12 in the modern diagnosis of pernicious anemia].
    Grál T; Grál J
    Med Welt; 1965 Jun; 24():1334-6. PubMed ID: 5828642
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitamin B 12 malabsorption due to a biologically inert intrinsic factor.
    Katz M; Lee SK; Cooper BA
    N Engl J Med; 1972 Aug; 287(9):425-9. PubMed ID: 5044916
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studying the absorption of Co58 labelled vitamin B12 by total body counter in patients with pernicious anemia and malabsorption].
    Keszthelyi B; Tóth A; Novotny S; Past T; Jávor T
    Orv Hetil; 1975 Jan; 116(2):79-83. PubMed ID: 1109483
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of vitamin B 12 malabsorption in blind loop syndrome: bacterial uptake of vitamin B 12 and stability of binding of vitamin B 12 to gastric intrinsic factor.
    Nakajima T; Abe T; Okamura H
    Bull Tokyo Med Dent Univ; 1972 Dec; 19(4):311-31. PubMed ID: 4569981
    [No Abstract]   [Full Text] [Related]  

  • 26. A rapid quantitative method for measuring intestinal absorption of vitamin B 12 in man using a double label hepatic uptake test.
    Weisberg H; Glass GB
    J Lab Clin Med; 1966 Jul; 68(1):163-72. PubMed ID: 5945625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of the Schilling test using cyanocobalamin, hydroxocobalamin and coenzyme B12].
    Abe T; Nakajima T; Okamura H
    Saishin Igaku; 1967 Feb; 22(2):352-3. PubMed ID: 6064824
    [No Abstract]   [Full Text] [Related]  

  • 28. HYDROXOCOBALAMIN: EXCRETION AND RETENTION AFTER PARENTERAL DOSES IN ANEMIC AND NONANEMIC SUBJECTS, WITH REFERENCE TO THE TREATMENT OF VITAMIN B12 DEFICIENCY STATES.
    ADAMS JF; KENNEDY EH
    J Lab Clin Med; 1965 Mar; 65():450-8. PubMed ID: 14261326
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma absorption of cyanocobalamin Co 57. Diagnostic value in vitamin B12 malabsorption states.
    Doscherholmen A; Ripley D
    Arch Intern Med; 1974 Dec; 134(6):1019-24. PubMed ID: 4473962
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired assimilation of egg Co 57 vitamin B 12 in patients with hypochlorhydria and achlorhydria and after gastric resection.
    Doscherholmen A; Swaim WR
    Gastroenterology; 1973 May; 64(5):913-9. PubMed ID: 4633664
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma clearance of heated serum bound Co57-vitamin B12.
    Levanto A; Salmi HA; Miller IF; Meyer LM
    Acta Haematol; 1969; 41(2):102-5. PubMed ID: 4977430
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydroxocobalamin. Excretion and retention of repeated large doses in patients with pernicious anaemia.
    Killander A; Werner I
    Acta Med Scand; 1968 Nov; 184(5):393-4. PubMed ID: 5732554
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dosage of hydroxocobalamin (Vibeden)].
    Skouby AP
    Ugeskr Laeger; 1970 Jan; 132(5):208-13. PubMed ID: 5446563
    [No Abstract]   [Full Text] [Related]  

  • 34. THE URINARY EXCRETION AND TISSUE RETENTION OF CYANOCOBALAMIN BY SUBJECTS GIVEN REPEATED PARENTERAL DOSES.
    ADAMS JF
    J Clin Pathol; 1964 Jan; 17(1):31-8. PubMed ID: 14099998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competition between bacteria and intrinsic factor for vitamin B 12 : implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth.
    Giannella RA; Broitman SA; Zamcheck N
    Gastroenterology; 1972 Feb; 62(2):255-60. PubMed ID: 4629318
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of hydroxocobalamin and cyanocobalamin in the treatment of pernicious anaemia.
    Chalmers JN; Shinton NK
    Lancet; 1965 Dec; 2(7426):1305-8. PubMed ID: 4165301
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical uses of radio- active vitamin B 12].
    Zanzi I; Meza-Arrau C; Litvak J; Larrain C
    Sangre (Barc); 1965; 10(3):299-304. PubMed ID: 5864592
    [No Abstract]   [Full Text] [Related]  

  • 38. Excretion of cobalamins and coenzyme B 12 following massive parenteral doses.
    Boddy K; Adams JF
    Am J Clin Nutr; 1968 Jun; 21(6):657-64. PubMed ID: 5666644
    [No Abstract]   [Full Text] [Related]  

  • 39. Microbial degradation of corrinoids. VI. Reduction of hydroxocobalamin by cell-free particles from Pseudomonas rubescens.
    Hufham JB; Burgus RC; Ing SY; Pfifner JJ
    J Bacteriol; 1968 Mar; 95(3):947-51. PubMed ID: 4384487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyanocobalamin and cyanide toxicity.
    Sawyer DR
    Am Fam Physician; 1982 Jul; 26(1):48, 50, 55. PubMed ID: 7090966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.